FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
25/06/2026
Voltar para busca
Dado oficial do USPTO
ENOSIUM LIFE SCIENCE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ENOSIUM LIFE SCIENCE
ST13
US500000079412443Classe
35, 41
Pedido
79412443
Registro
8026592
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
25/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 41
Data de depósito
13/11/2024
Data de registro
18/11/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/11/2025
Última transação
25/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
01
Localização do titular
Saint-Nom-La-Bretèche, FR
Examinador
LAVACHE, LINDA M
Unidade examinadora
L60
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
A. A. (pessoa física)
Representantes
Milena S. Mishev Grossman Tucker Perreault & Pfleger, PLL
Classificação técnica
Classes Nice
Classe 35Classe 41
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business management advice in the fields of healthbiotechnology and pharmacy; business management assistance in the fields of healthbiotechnology and pharmacy; cost price analysis of medicalpharmaceutical and biotechnological products; market research and analysis services in the fields of healthbiotechnology and pharmacy; business administration and commercial assistance in business management in the fields of healthbiotechnology and pharmacy; commercial analysisproviding corporate business auditing services with respect to the medicalpharmaceutical and biotechnological fields; compilation of scientificmedical and pharmaceutical information for commercial or advertising purposes; providing advice concerning advertising communication strategies in the fields of healthbiotechnology and pharmacy; development of marketing concepts in the fields of healthbiotechnology and pharmacy; development of corporate business organization strategies in the fields of healthbiotechnology and pharmacy; market research in the fields of healthbiotechnology and pharmacy; providing marketing consulting to pharmaceutical and biotechnology companies for marketing new medicines and/or medical protocols; providing competitive business intelligence services in the medicalbiotechnology and pharmaceutical fields; market opinion polling in the medicalbiotechnology and pharmaceutical fields
Classe 41
Education servicesarranging and conducting classesseminarsworkshops and training in the medicalbiotechnology and pharmaceutical fields; organization of seminarscolloquiumsconferencesworkshops in the pharmaceuticalmedicalhealthcarelife sciences fields; educational and training servicesorganizing conferences to train physicianspharmacistsother medical providers in conducting clinical trials; providing education servicesarranging and conducting classesseminarsworkshops and training in the pharmaceuticalmedicalhealthcarelife sciences fields; providing online non-downloadable publications in the nature of brochuresreports and books in the pharmaceuticalmedicalhealthcarelife sciences fields; medicalbiotechnological and pharmaceutical education appraisal serviceseducational examination services in the fields of medicinebiotechnology and pharmacy; medicalbiotechnological and pharmaceutical education servicesarranging and conducting classesseminarsworkshops in the fields of medicinebiotechnology and pharmacy
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/06/2026
FIMP
FINAL DISPOSITION PROCESSED
05/06/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/06/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/05/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
18/05/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
18/02/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
18/11/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
18/11/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/09/2025
PUBO
PUBLISHED FOR OPPOSITION
30/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/09/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
03/09/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/09/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
03/09/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/08/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/08/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/08/2025
RFNT
REFUSAL PROCESSED BY IB
12/07/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/06/2025
RFRR
REFUSAL PROCESSED BY MPU
22/06/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
24/04/2025
CNRT
NON-FINAL ACTION WRITTEN
23/04/2025
DOCK
ASSIGNED TO EXAMINER
16/04/2025
MAFR
APPLICATION FILING RECEIPT MAILED
20/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/12/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/12/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ENOSIUM LIFE SCIENCE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.